Sub-assembly of medicament delivery device

By designing the tubular outer cap, inner cap and clutch mechanism in the drug delivery device, combined with the interlocking sleeve and retainer, the problem of confusion in the cap separation and operation of the drug delivery device is solved, and operation safety and reliability are improved .

CN118973642APending Publication Date: 2024-11-15SHL MEDICAL AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380031175.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-19
Filing Date
2023-04-05
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Improper operation of the drug delivery device results in accidental separation of the cap of the drug delivery device or difficulty for the user to follow the operating instructions, especially when used between multiple or more devices, which can easily lead to confusion and erroneous operation.

Method used

A subassembly of a medicament delivery device is designed, including a tubular outer cap and an inner cap, which enables rotatable separation of the cap through a clutch mechanism and ensures correct attachment and displacement of the cap through an interlocking sleeve and retainer. In addition, prevent accidental separation while providing delivery member hub and locking member for operational safety.

Benefits of technology

Effectively prevent accidental separation of the cap of the drug delivery device, ensure that the user follows the correct operating steps, reduce operation errors, and improve the safety and reliability of drug delivery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118973642A_ABST
    Figure CN118973642A_ABST
Patent Text Reader

Abstract

A sub-assembly of a medicament delivery device, the sub-assembly comprising: a tubular outer cap extending along a longitudinal axis; an inner cap at least partially surrounded by a tubular outer cap; wherein the inner cap is configured to be removably attached to the housing of the medicament delivery device via a rotational attachment; a clutch formed by a driving portion and a driven portion; wherein the driven portion is attached to the inner cap and positioned between the tubular outer cap and the inner cap in a direction transverse to the longitudinal axis; wherein the outer cap is axially movable relative to the inner cap between a proximal position and a distal position; wherein the tubular outer cap includes a drive portion extending from a body of the tubular outer cap; wherein the driven portion extends towards the tubular outer cap in a direction transverse to the longitudinal axis; wherein the driving portion is spaced apart from the driven portion in the direction of the longitudinal axis when the tubular outer cap is in the proximal position; and wherein when the tubular outer cap is in the distal position, the driving portion is adjacent to the driven portion such that the inner cap is separable from the housing of the medicament delivery device via rotation of the outer cap relative to the housing of the medicament delivery device.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates generally to subassemblies of medicament delivery devices, and in particular to subassemblies having clutches. Background Art

[0002] Drug delivery devices such as pen-type manual injectors or auto-injectors are commonly known for self-administration of drugs by patients without formal medical training. For example, a diabetic patient may require repeated injections of insulin, or a patient may require regular injections of other types of drugs, such as growth hormone.

[0003] Therefore, clear operation instructions for patients are important. However, not every user carefully reads the user instructions or instructions on the package every time before performing a drug delivery operation, or sometimes unintentional contact with the drug delivery device may occur, for example, accidentally separating the cap of the drug delivery device; or some end users need to perform multiple drug delivery operations using multiple different drug delivery devices, and will easily confuse or mix up the drug delivery device operation instructions between different drug delivery devices.

[0004] Therefore, a structural design of a drug delivery device that can ensure that a user follows the operating instructions of the drug delivery device is desirable. Summary of the invention

[0005] The present invention is defined by the appended claims, to which reference should now be made.

[0006] In the present disclosure, when the term "distal direction" is used, this refers to a direction pointing away from a dose delivery site during use of the injection device. When the term "distal portion / distal end" is used, this refers to a portion / end of a delivery device or a portion / end of a component of a delivery device that is positioned furthest from a dose delivery site during use of the injection device. Correspondingly, when the term "proximal direction" is used, this refers to a direction pointing towards a dose delivery site during use of the injection device. When the term "proximal portion / proximal end" is used, this refers to a portion / end of a delivery device or a portion / end of a component of a delivery device that is positioned closest to a dose delivery site during use of the injection device.

[0007] Additionally, the terms "longitudinal," "longitudinally," "axially," and "axial" refer to a direction extending from a proximal end to a distal end, typically along a device or component thereof in the direction of longest extension of the device and / or component.

[0008] Similarly, the terms "lateral," "transverse," and "transversely" refer to a direction generally perpendicular to the longitudinal direction.

[0009] Additionally, the terms "circumferential," "circumferential," or "circumferentially" refer to circumferential or circumferential directions relative to an axis, which is typically a central axis extending in the direction of longest extension of the device and / or component. Similarly, "radial" or "radially" refer to directions extending radially relative to an axis, and "rotational," "rotational," and "rotationally" refer to rotation relative to an axis.

[0010] Therefore, a subassembly of a drug delivery device is provided, the subassembly comprising: a tubular outer cap extending along a longitudinal axis; and an inner cap at least partially surrounded by the tubular outer cap. The inner cap is configured to be removably attached to the housing of the drug delivery device via rotational attachment. The clutch is formed by a driving portion and a driven portion. The driven portion is attached to the inner cap and positioned between the tubular outer cap and the inner cap in a direction transverse to the longitudinal axis. The outer cap can be axially moved between a proximal position and a distal position relative to the inner cap. The tubular outer cap includes a driving portion extending from the main body of the tubular outer cap. The driven portion extends toward the tubular outer cap in a direction transverse to the longitudinal axis. When the tubular outer cap is in a proximal position, the driving portion is spaced apart from the driven portion in the direction of the longitudinal axis. When the tubular outer cap is in a distal position, the driving portion is adjacent to the driven portion, so that the inner cap can be separated from the housing of the drug delivery device via the rotation of the outer cap relative to the housing of the drug delivery device.

[0011] Preferably, according to another embodiment, the driven portion extends from the body wall of the inner cap in a direction transverse to the longitudinal axis.

[0012] Alternatively, according to another embodiment, the subassembly includes an interlocking sleeve. The interlocking sleeve includes a body extending along the longitudinal axis. The interlocking sleeve includes a rotating sleeve fastener engaged with a mating rotating sleeve fastener of the inner cap. The driven portion extends from the body of the interlocking sleeve in a direction transverse to the longitudinal axis.

[0013] Preferably, according to another embodiment, the interlocking sleeve comprises an axial sleeve fastener engaged with a mating axial sleeve fastener of the inner cap. Preferably, according to another embodiment, the engagement formed between the rotating sleeve fastener engaged with the mating rotating sleeve fastener of the inner cap is formed by a rib and a mating rib, or by a rib and a groove, or by a non-circular cross-sectional body and another non-circular cross-sectional body.

[0014] Preferably, according to another embodiment, the engagement formed between the axial sleeve fastener engaged with the mating rotating sleeve fastener of the inner cap is formed by a snap-fit ​​engagement.

[0015] Preferably, according to another embodiment, one of the driving portion and the driven portion is a recess, and the other of the driving portion and the driven portion is a protrusion positioned in the recess when the tubular outer cap is in the distal position.

[0016] Preferably, according to another embodiment, the recess faces in a direction transverse to the longitudinal axis.

[0017] Preferably, according to another embodiment, the recess is formed by a ratchet.

[0018] Alternatively, according to another embodiment, the clutch engagement between the driving portion and the driven portion is formed by mating a non-circular cross-sectional body of the driving portion with a non-circular cross-sectional body of the driven portion.

[0019] Preferably, according to another embodiment, the clutch engagement formed between the driving part and the driven part is a friction fit engagement.

[0020] Preferably, according to another embodiment, the subassembly comprises and a retainer.

[0021] Preferably, according to another embodiment, the retainer includes a retainer body and an attachment extending from the retainer body. The attachment is configured to be attached to a mating attachment of a drug delivery device. The inner cap is removably attached to the retainer via a rotational attachment, whereby the inner cap is removably attached to the drug delivery device via the retainer.

[0022] Preferably, according to another embodiment, the attachment of the holder is one of a snap-fit ​​attachment, a threaded attachment and a bayonet attachment.

[0023] Preferably, according to another embodiment, the rotational attachment is formed by a thread of the holder body and a thread follower of the inner cap engaging with the thread of the holder.

[0024] Preferably, according to another embodiment, the subassembly includes a delivery member hub configured to be attached to the drug delivery member. The delivery member hub includes a first engagement member engaged with a first mating engagement member of the retainer, and the delivery member hub includes a second engagement member engaged with a mating second engagement member of the inner cap. The delivery member hub is axially movable relative to the retainer body between a proximal position and a distal position.

[0025] Preferably, according to another embodiment, rotation of the inner cap relative to the retainer is configured to move the delivery member hub from the proximal position to the distal position.

[0026] Preferably, according to another embodiment, the engagement formed between the first engagement member and the mating first engagement member is a threaded engagement. The engagement formed between the second engagement member and the mating second engagement member is a rotational engagement.

[0027] Preferably, according to another embodiment, the threaded engagement between the delivery member hub and the retainer is directed in an opposite longitudinal direction relative to the threaded engagement between the inner cap and the retainer.

[0028] Preferably, according to another embodiment, the delivery member hub is rotationally fixed to the holder body. One of the second engagement member and the mating second engagement member is a spiral cam, and the other of the second engagement member and the mating second engagement member is a cam follower. The engagement formed between the first engagement member and the mating first engagement member is a snap-fit ​​engagement.

[0029] Alternatively, according to another embodiment, the outer cap is axially movable relative to the housing of the drug delivery device from an initial proximal position to a proximal position, and the outer cap is not axially movable relative to the inner cap when the outer cap moves from the proximal position to the proximal position.

[0030] Preferably, according to another embodiment, axial movement of the inner cap relative to the retainer is configured to move the delivery member hub from a proximal position to a distal position.

[0031] Preferably, according to another embodiment, the delivery member hub is configured to snap fit to the holder.

[0032] Preferably, according to another embodiment, the subassembly includes a delivery member guard and a locking member. The delivery member guard includes a proximal reference surface adjacent to the distal reference surface of the tubular outer cap. The delivery member guard includes a distal reference surface. The locking member includes a body having a proximal reference surface. The locking member is capable of moving between a locked position and an unlocked position relative to the delivery member guard, in which the proximal reference surface of the locking member is aligned with the distal reference surface of the delivery member guard so that the delivery member guard is prevented from moving distally relative to the locking member, and in the unlocked position, the proximal reference surface of the locking member is offset toward the distal reference surface of the delivery member guard so that the delivery member guard can move distally relative to the locking member.

[0033] Preferably, according to another embodiment, the locking member is rotatable relative to the delivery member guard about the longitudinal axis between a locked position and an unlocked position.

[0034] Alternatively, according to another embodiment, the locking member is slidable relative to the delivery member guard in a direction transverse to the longitudinal axis.

[0035] Preferably, according to another embodiment, the drug delivery device is a disposable drug delivery device.

[0036] Alternatively, according to another embodiment, the drug delivery device is a reusable drug delivery device.

[0037] Preferably, according to another embodiment, the reusable drug delivery device is formed by a disposable cartridge unit and a reusable drive unit.

[0038] Preferably, according to another embodiment, the medicament delivery device is an autoinjector.

[0039] Another aspect of the present invention provides a cassette unit for a drug delivery device, the cassette unit for a drug delivery device comprising the subassembly.

[0040] Preferably, according to another embodiment, the cassette unit comprises a housing of the medicament delivery device. The housing extends along a longitudinal axis. The locking member is axially fixed to the housing.

[0041] Preferably, according to another embodiment, the delivery member guard is rotationally fixed to the housing. The housing includes a bayonet projection, which is configured to move along a bayonet track of a drive unit of the drug delivery device, thereby attaching the cassette unit to the drive unit. The locking member includes a projection extending from the body away from the longitudinal axis. The projection is adjacent to the bayonet projection of the housing in the direction of the longitudinal axis. The projection is configured to be rotationally fixed to the wall of the drive unit when the cassette unit is attached to the drive unit.

[0042] Preferably, according to another embodiment, the drug delivery device comprises a multi-chamber drug container arranged in the carrier.

[0043] Preferably, according to another embodiment, the drug delivery device is an autoinjector or a manual insulin pen.

[0044] Preferably, according to another embodiment, the medicament container is a medicament container without a medicament delivery member.

[0045] Preferably, according to another embodiment, the medicament container is a glass cartridge, a plastic cartridge or a collapsible bag.

[0046] Another aspect of the present invention provides a method for removing a cap of a drug delivery device, wherein the drug delivery device comprises a cassette unit and a drive unit, the method comprising the following steps in the following order:

[0047] moving the locking member from a locked position to an unlocked position;

[0048] moving the tubular outer cap and the delivery member guard in a distal direction relative to the inner cap to a distal position of the tubular outer cap;

[0049] The tubular outer cap and the inner cap are rotated relative to the housing of the cassette unit, thereby separating the tubular outer cap and the inner cap from the housing of the cassette unit.

[0050] Preferably, according to another embodiment, the step of moving the locking member from the locked position to the unlocked position comprises the step of rotating the locking member relative to the delivery member guard from the locked position to the unlocked position.

[0051] Preferably, according to another embodiment, the step of rotating the locking member relative to the delivery member guard from the locked position to the unlocked position comprises the following step: during attachment of the cassette unit to the drive unit via the bayonet connection, rotating the locking member relative to the delivery member guard from the locked position to the unlocked position.

[0052] Preferably, according to another embodiment, the step of rotating the tubular outer cap and the inner cap relative to the shell also includes the following steps: during the rotation of the tubular outer cap and the inner cap relative to the shell, moving the delivery member hub from the proximal position to the distal position, thereby mounting the delivery member attached to the delivery member hub to the drug container of the shell having the drug delivery device.

[0053] The injection devices described herein can be used to treat and / or prevent one or more of many different types of diseases. Exemplary diseases include, but are not limited to, rheumatoid arthritis, inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis), hypercholesterolemia, diabetes (e.g., type 2 diabetes), psoriasis, migraine, multiple sclerosis, anemia, lupus, atopic dermatitis, asthma, nasal polyps, acute hypoglycemia, obesity, anaphylaxis, and allergic reactions. Exemplary agent types that may be included in the injection devices described herein include, but are not limited to, antibodies, proteins, fusion proteins, peptibodies, polypeptides, pegylated proteins, protein fragments, protein analogs, protein variants, protein precursors, and / or protein derivatives. Exemplary pharmaceutical agents that may be included in the injection devices described herein include, but are not limited to (non-limiting examples of relevant diseases are in parentheses): etanercept (rheumatoid arthritis, inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis)), evolocumab (hypercholesterolemia), exenatide (type 2 diabetes), secukinumab (psoriasis), efrenizumab (migraine), alirocumab (rheumatoid arthritis), methotrexate (rheumatoid arthritis), tocilizumab (rheumatoid arthritis), interferon beta-1a (multiple sclerosis), and levofloxacin (drug therapy). ), sumatriptan (migraine), adalimumab (rheumatoid arthritis), darbepoetin alpha (anemia), belimumab (lupus), peginterferon beta-1a' (multiple sclerosis), salilumab (rheumatoid arthritis), semaglutide (type 2 diabetes, obesity), dupilumab (atopic dermatitis, asthma, nasal polyps, allergies), glucagon (acute hypoglycemia), epinephrine (anaphylaxis), insulin (diabetes), atropine and vedolizumab (inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis)). Pharmaceutical preparations including, but not limited to, any of the agents described herein are also contemplated for use in the injection devices described herein, such as pharmaceutical preparations comprising the agents listed herein (or pharmaceutically acceptable salts of the agents) and a pharmaceutically acceptable carrier. Pharmaceutical preparations comprising the drugs listed herein (or pharmaceutically acceptable salts of the drugs) may include one or more other active ingredients, or may be the only active ingredient present.

[0054] Furthermore, unless otherwise expressly defined herein, all terms used in the claims should be interpreted according to their ordinary meaning in the technical field. Unless otherwise expressly stated, all references to an element, device, component, device, etc. should be openly interpreted as referring to at least one instance of an element, device, component, device, etc. BRIEF DESCRIPTION OF THE DRAWINGS

[0055] Embodiments of the present inventive concept will now be described, by way of example only, with reference to the accompanying drawings, in which

[0056] In the figure:

[0057] Figure 1 to Figure 2 A perspective view of a subassembly of the present invention is schematically shown.

[0058] Figure 3 Schematically shows Figure 1 to Figure 2 The inner cap and delivery member hub of the subassembly.

[0059] Figure 4 Schematically shows Figure 1 to Figure 2 The inner cap and interlocking sleeve of the subassembly.

[0060] Figure 5 Schematically shows Figure 1 to Figure 2 The interlocking sleeve and tubular outer cap of the subassembly.

[0061] FIG. 6A to FIG. 6B Schematically shows Figure 1 to Figure 2 A sequence of operations on the subcomponents of a .

[0062] Figure 7 Schematically shows Figure 1 to Figure 2 A perspective view of the subassemblies, delivery member guard and locking member.

[0063] Figure 8 Schematically shows Figure 7 Perspective view of a delivery member guard and locking member.

[0064] FIG. 9A to FIG. 9B Schematically shows Figure 8 Perspective view of a delivery member guard and locking member.

[0065] Fig.10 A perspective view of a drug delivery device having a subassembly of the present invention is schematically shown.

[0066] FIG. 11A to FIG. 11B Schematically shows Fig.10 An operating sequence of a drug delivery device. DETAILED DESCRIPTION

[0067] Figures 1 to 6B A subassembly of a drug delivery device is illustrated. The subassembly 1 comprises a tubular outer cap 10, an inner cap 12 and a clutch.

[0068] like Figure 1 to Figure 2 As shown, the tubular outer cap 10 extends along a longitudinal axis L between a proximal end and a distal end. The tubular outer cap 10 includes a body 100. The tubular outer cap 10 is configured to be grasped by a user and is configured to be removed from the drug delivery device before a drug delivery operation. Figure 1As shown, the outer cap 10 is generally cylindrical. In one example, the outer surface of the body 100 includes an indicator mark for indicating to the user the action for removing the cap, such as rotation. In another example, the outer surface of the body includes a plurality of recesses and protrusions so that the user can easily and tightly grasp the outer cap. Alternatively, the outer cap can be formed into different shapes as needed (e.g., patient groups).

[0069] The inner cap 12 includes a body 120 configured to enclose at least a portion of a drug delivery component of a drug delivery device. Figure 2 In the example shown, the body 120 of the inner cap 12 is generally cylindrical. The body 120 of the inner cap is at least partially surrounded by the tubular outer cap 10. The inner cap 12 is configured to be removably attached to the housing of the drug delivery device via a rotational attachment. In one example, as shown in FIG. Figure 2 As shown, the rotational attachment is a threaded engagement. In this example, one of the inner cap and the housing of the drug delivery device includes threads, and the other of the inner cap and the housing of the drug delivery device includes a thread follower, such as a protrusion or thread. In this example, the inner cap 12 includes threads 123 extending the body 120 of the inner cap, and the housing of the drug delivery device operably includes mating threads 111, such as Figures 2 to 3 As shown. The mating thread may be arranged on an integral part of the housing of the drug delivery device. Alternatively, the mating thread may be arranged on another component independent of the housing of the drug delivery device and configured to be attached to the housing of the drug delivery device before use of the drug delivery device.

[0070] In a preferred example, the subassembly 1 includes a retainer 11, which includes a retainer body 110, and a mating thread 111 extends from the outer surface of the retainer 11, and the retainer is configured to be attached to the housing of a drug delivery device. For example, the attachment 11a extending from the retainer body 110 is configured to be attached to the mating attachment of the drug delivery device, such as Figure 1 As shown, the attachment 11a is a snap fit hook and the mating attachment may be a snap fit recess / cutout. Alternatively, the attachment and mating attachment may be a thread and a thread follower, such as a protrusion or another matching thread.

[0071] Alternatively, the rotational attachment may be a bayonet attachment. In this example, one of the inner cap and the housing of the drug delivery device includes a bayonet track, and the other of the inner cap and the housing of the drug delivery device includes a bayonet follower, such as a protrusion. Similarly, the bayonet track or the bayonet follower may be formed on a retainer 11 that is configured to be attached to the housing, or as an integral part of the housing. The outer cap 10 is axially movable relative to the inner cap 12 between a proximal position and a distal position.

[0072] The clutch is formed by the driving portion 101 and the driven portion 132. The driven portion 132 is attached to the inner cap 12 and is positioned in a direction transverse to the longitudinal axis L between the tubular outer cap 10 and the inner cap 12.

[0073] The tubular outer cap 10 includes a driving portion 101 extending from the body 100 of the tubular outer cap 10. The driven portion 132 extends toward the tubular outer cap 10 in a direction transverse to the longitudinal axis. Therefore, when the driving portion 101 is adjacent to the driven portion 132, the user can rotate the inner cap 12 together with the outer cap 10 via the clutch engagement between the driving portion 101 and the driven portion 132.

[0074] When the tubular outer cap 10 is in the proximal position, the driving portion 101 is spaced apart from the driven portion 132 in the direction of the longitudinal axis L, so that the rotation of the outer cap 10 relative to the housing of the drug delivery device around the longitudinal axis L will not be converted into the rotation of the inner cap 12. In other words, when the outer cap is in the proximal position, the outer cap 10 will rotate relative to the inner cap 12. When the tubular outer cap 10 is in the distal position, the driving portion 101 is adjacent to the driven portion 132, so that the inner cap 12 can be separated from the housing of the drug delivery device via the rotation of the outer cap 10 relative to the housing of the drug delivery device.

[0075] Optionally, the subassembly 1 includes an interlocking sleeve 13. The interlocking sleeve 13 includes a body 130 extending along the longitudinal axis L. The interlocking sleeve is configured to be attached to the inner cap 12 and positioned between the inner cap 12 and the outer cap 10 in a direction transverse to the longitudinal axis L. In a preferred example, the shape of the body 130 of the interlocking sleeve 13 depends on the shape of the inner cap 12 and the shape of the outer cap 10. For example, when both the outer cap 10 and the inner cap 12 are formed into a generally cylindrical shape, the body 130 of the interlocking sleeve 13 is also generally cylindrical, such as Figure 2 and Figure 5 The interlocking sleeve 13 is not capable of rotational movement relative to the inner cap 12 , so that the inner cap 12 can be removed from the housing of the drug delivery device via rotation of the interlocking sleeve 13 relative to the housing.

[0076] Optionally, the interlocking sleeve 13 is also unable to move axially relative to the inner cap 12. In one example, the interlocking sleeve 13 includes an axial sleeve fastener 131 that engages with the mating axial sleeve fastener 122 of the inner cap 12, and the interlocking sleeve includes a rotating sleeve fastener 133 that engages with the mating rotating sleeve fastener 121. In one example, the axial sleeve fastener 131 is a snap-fit ​​hook, and the mating axial sleeve fastener 122 is a snap-fit ​​recess, such as Figure 2In one example, the rotating sleeve fastener 133 of the interlocking sleeve is a non-circular cross-sectional main body portion of the main body 130 of the interlocking sleeve 12, and the mating rotating sleeve fastener 121 of the inner cap 12 is a non-circular cross-sectional main body portion of the main body 120 of the inner cap 12 that matches the rotating sleeve fastener 133 of the interlocking sleeve 13, as shown in FIG. Figures 4 to 5 shown.

[0077] It should be noted that when a non-circular cross-sectional body of one component is used to mate with another non-circular cross-sectional body of another component, a rotational joint is formed, which means that the two components can now only rotate together with each other. For example, the non-circular cross-sectional body can be a polygonal cross-sectional body, a star-shaped cross-sectional body or a heart-shaped cross-sectional body.

[0078] In this example, the follower portion 132 extends from the body 130 of the interlocking sleeve 13 in a direction transverse to the longitudinal axis L. Alternatively, the follower portion extends from the body wall of the inner cap in a direction transverse to the longitudinal axis L, so an interlocking sleeve is not required in this example.

[0079] In one example, one of the driving portion 101 and the driven portion 132 is a recess; and the other of the driving portion 101 and the driven portion 132 is a protrusion positioned in the recess when the tubular outer cap 10 is in the distal position. Figure 5 As shown, the driving portion 101 is a recess and the driven portion is a protrusion. In one example, the recess faces a direction transverse to the longitudinal axis L. In a preferred example, the recess is formed by a ratchet so that the user does not accidentally fasten the inner cap to the housing of the drug delivery device by twisting the inner cap in the wrong direction. Alternatively, the clutch engagement formed between the driving portion and the driven portion is formed by matching the non-circular cross-sectional body of the driving portion with the non-circular cross-sectional body of the driven portion. Alternatively, the clutch engagement formed between the driving portion and the driven portion is a friction fit engagement.

[0080] Subassembly 1 of the present invention can be used for a drug delivery device, which includes a drug container with an integrated drug delivery member. In this example, subassembly 1 prevents the user from accidentally separating the inner cap, such as twisting the inner cap. Alternatively, subassembly 1 can be used for a drug delivery device, which includes a drug container without a drug delivery member, such as a cartridge or a collapsible bag, especially for a drug delivery device with a drug container without a drug delivery member and a preassembled drug delivery member (such as a needle or a nozzle). Subassembly 1 of the present invention can be used with a mechanism for establishing fluid communication between a drug delivery member and a drug container without a drug delivery member.

[0081] In one example where the subassembly includes a retainer 11, the subassembly includes a delivery member hub 14 configured to be attached with a drug delivery member. The delivery member hub has a body 140 extending between a proximal end and a distal end along a longitudinal axis L. The delivery member is configured to extend through a proximal end of the body 140 of the delivery member hub 14 and a distal end of the body 140 of the delivery member hub 14. In a preferred example, the drug delivery member is glued to the body 140 of the delivery member hub 14.

[0082] In this example, the holder body 110 includes a central cavity configured to receive the body of the delivery member hub 14. In this example, the central cavity of the holder body 110 is configured to align with the medication container of the medication delivery device in the direction of the longitudinal axis L so that the delivery member can be attached to the medication container through the central cavity. In this example, the delivery member hub 14 includes a first engagement member 141 engaged with the first mating engagement member 112 of the holder 11 and a second engagement member 142 engaged with the mating second engagement member 124 of the inner cap 12. The delivery member hub 14 is axially movable relative to the holder body 110 between a proximal position and a distal position.

[0083] In one example, if Figure 2 As shown, the rotation of the inner cap 12 relative to the retainer 11 is configured to move the delivery member hub 14 from a proximal position to a distal position. In one example, the engagement formed between the first engagement member and the mating first engagement member is a threaded engagement. The engagement formed between the second engagement member and the mating second engagement member is a rotational engagement. In this example, the threaded engagement between the delivery member hub and the retainer points in a longitudinal direction opposite to the threaded engagement between the inner cap and the retainer. For example, the first engagement member 141 is a helical protrusion 141 extending from the body 140 of the delivery member hub 14, and the mating first engagement member 112 is a thread 112 extending from the inner surface of the central cavity of the retainer body 110, as shown in FIG. Figure 2 The second engagement member 142 is a cutout in the wall of the body 140 of the delivery member hub 14, preferably at the proximal end of the body 140 of the delivery member hub 14, and the mating second engagement member 124 is a protrusion 124 extending from the inner surface of the body 120 of the inner cap 12, as shown. Figure 3 As shown. Therefore, when the inner cap 12 is rotated relative to the holder 11 to be separated from the holder 11, the delivery member hub 14 rotates together with the delivery member in the opposite direction. Thereby, the delivery member hub 14 and the delivery member move in the distal direction of the outer cap to attach to the holder 11 and establish fluid communication with the drug container of the drug delivery device.

[0084] Alternatively, the delivery member hub is rotationally fixed to the holder body. In this example, one of the second engagement member and the mating second engagement member is a spiral cam, and the other of the second engagement member and the mating second engagement member is a cam follower. In addition, the engagement formed between the first engagement member and the mating first engagement member is a snap-fit ​​engagement. Therefore, rotation of the inner cap relative to the holder moves the delivery member hub from a proximal position to a distal position, and thereby establishes fluid communication with the medication container and the delivery member of the medication delivery device.

[0085] Alternatively, the rotation of the inner cap can be used only to separate the inner cap from the retainer. In this example, the inner cap includes a distal reference surface adjacent to the proximal reference surface of the delivery member hub, and the outer cap cannot move axially relative to the inner cap between the initial proximal position and the proximal position. For example, the outer cap includes a protrusion extending from the inner surface of the outer cap in a direction transverse to the longitudinal axis, and the inner cap includes a mating protrusion that engages with the protrusion of the outer cap when the outer cap is in the initial proximal position and separates from the protrusion of the outer cap when the outer cap is in the proximal position. In a preferred example, the interface between the protrusion and the mating protrusion is inclined relative to the longitudinal axis L. In this example, one of the first engaging member of the hub and the mating first engaging member of the retainer is a snap-fit ​​hook, and the other of the first engaging member of the hub and the mating first engaging member of the retainer is a recess / cutout. In this example, when the user pushes the outer cap in the distal direction relative to the housing of the drug delivery device, the outer cap, the inner cap and the delivery member hub move together in the distal direction relative to the retainer until the delivery member hub snap fits the retainer. When the delivery member hub snap fits the retainer, the delivery member hub cannot move in the distal direction relative to the retainer, and therefore the inner cap cannot move in the distal direction relative to the retainer. Therefore, if the user continues to push the outer cap in the distal direction relative to the housing of the drug delivery device, the protrusion of the outer cap moves through the matching protrusion of the inner cap. Preferably, in this example, the engagement between the inner cap and the retainer is a track and a protrusion engagement. For example, the inner cap includes a protrusion positioned in the track of the retainer. The track includes a longitudinal section extending between the proximal end and the distal end along the longitudinal axis and a circumferential section extending between the first end and the second end around the longitudinal axis. The proximal end of the longitudinal section of the track is a closed end, and the distal end of the longitudinal section of the track is connected to the first end of the circumferential section. The second end of the circumferential segment is an open end, wherein the protrusion is removable from the track at the second end.

[0086] In this example, when the outer cap moves from the initial proximal position to the proximal position, the bayonet protrusion of the inner cap moves along the longitudinal section of the bayonet track of the retainer. When the outer cap moves further from the proximal position to the distal position, the inner cap cannot move relative to the retainer, and when the outer cap is in the distal position, the outer cap is rotationally engaged with the inner cap via the clutch as described above. Therefore, the user can rotate the outer cap, whereby the protrusion of the inner cap moves from the first end to the second end along the circumferential section of the track, so that the inner cap is separated from the retainer.

[0087] It should be noted that the structure on the holder may be arranged on the housing of the drug delivery device according to the design.When the subassembly 1 is used with a drug delivery device of this type, the subassembly does not have a holder.

[0088] In addition, the subassembly optionally includes an auxiliary safety mechanism. In this example, the subassembly includes a delivery member guard 2 and a locking member 3, such as Figure 7 In a preferred example, the delivery member shield includes a tubular proximal section 20 and a distal body section 21. The distal body section can be an arm extending distally from the tubular proximal section 20, such as Figure 8 As shown. Alternatively, the distal body segment can be cylindrical. The delivery member guard 2 includes a proximal reference surface 20a adjacent to the distal reference surface 102 of the tubular outer cap 10. In a preferred example, the proximal reference surface 20a is defined by the proximal end of the tubular proximal segment of the delivery member guard 2. Alternatively, the delivery member guard includes a protrusion extending from the outer surface of the tubular proximal segment in a direction transverse to the longitudinal axis, and the proximal reference surface is defined by the protrusion. The delivery member guard 2 includes a distal reference surface 22a. The locking member 3 includes a body 30 having a proximal reference surface 31a. The locking member 3 is capable of moving between a locked position and an unlocked position relative to the delivery member guard 2. In the locked position, the proximal reference surface 31a of the locking member 3 is aligned with the distal reference surface 22a of the delivery member guard 2, so that the delivery member guard 2 is prevented from moving distally relative to the locking member 3, as shown in FIG. Fig. 9A As shown, in the unlocked position, the proximal reference surface 31a of the locking member 3 is offset toward the distal reference surface 22a of the delivery member shield 2, as shown in FIG. Fig. 9B As shown, the delivery member shield 2 can be moved distally relative to the locking member 3. Therefore, when the locking member 3 is in the locked position, the outer cap 10 cannot move from the proximal position to the distal position. In an example in which the outer cap includes an initial proximal position, the outer cap cannot move from the initial proximal position to the proximal position. In one example, the delivery member shield 2 includes a rib 22 that extends from the distal body section of the delivery member shield 2 in a direction transverse to the longitudinal axis L.

[0089] In one example, the locking member 3 is rotatable relative to the delivery member guard 2 about the longitudinal axis L between a locked position and an unlocked position. For example, the locking member 3 can be a rotatable knob. In another example, the locking member can be linearly slidable from the locked position and the unlocked position in a direction transverse to the longitudinal axis L. For example, the locking member can be a removable pin configured to be removed by a user before use.

[0090] The subassembly can be used in a disposable drug delivery device, such as a handheld automatic syringe or an on-body injection pump. Alternatively, the subassembly can be used in a reusable drug delivery device formed by a disposable cassette unit C and a reusable power unit R, such as Fig.10 As shown. The disposable cassette unit C is configured to accommodate a medicament container. In one example in which the subassembly is used in a reusable medicament delivery device, the subassembly is used in a disposable cassette unit C. For example, the cassette unit includes a housing 4 of the medicament delivery device. The housing 4 extends along the longitudinal axis L. In this example, the locking member 3 is axially fixed to the housing 4. In a preferred example, the delivery member guard 2 is rotationally fixed to the housing 4. In a preferred example, the housing 4 includes a bayonet protrusion 40, which is configured to move along the bayonet track of the drive unit R of the medicament delivery device, thereby attaching the cassette unit C to the drive unit R. The locking member 3 includes a protrusion 32 extending from the main body 30 away from the longitudinal axis L. The protrusion 32 is adjacent to the bayonet protrusion 40 of the housing 4 in the direction of the longitudinal axis L. The protrusion 32 is configured to be rotationally fixed to the wall of the drive unit R when the cassette unit is attached to the drive unit R.

[0091] The subassembly can be operated with the reusable drug delivery device by the following steps: moving the locking member 3 from the locked position to the unlocked position; moving the tubular outer cap 10 and the delivery member guard 2 in the distal direction relative to the inner cap 12 to the distal position of the tubular outer cap 10; and rotating the tubular outer cap 10 and the inner cap 12 relative to the housing 4 of the cassette unit, thereby separating the tubular outer cap 10 and the inner cap 12 from the housing 4 of the cassette unit. In addition, the step of moving the locking member 3 from the locked position to the unlocked position includes the following steps: rotating the locking member 3 from the locked position to the unlocked position relative to the delivery member guard. In one example in which the cassette unit C is connected to the drive unit R via a bayonet connection, the step of rotating the locking member 3 from the locked position to the unlocked position relative to the delivery member guard 2 includes the following steps: rotating the locking member 3 from the locked position to the unlocked position relative to the delivery member guard 2 during the attachment of the cassette unit C to the drive unit R via the bayonet connection. In addition, when the subassembly is used together with a mechanism for establishing fluid communication between a drug delivery member and a drug container without the drug delivery member, the step of rotating the tubular outer cap 10 and the inner cap 12 relative to the housing 4 also includes the following steps: during the rotation of the tubular outer cap 10 and the inner cap 12 relative to the housing 4, the delivery member hub 14 is moved from a proximal position to a distal position, thereby mounting the delivery member attached to the delivery member hub 14 to a drug container of the housing 4 having the drug delivery device.

[0092] The inventive concept has mainly been described above with reference to a few examples. However, as is readily appreciated by a person skilled in the art, other embodiments than the ones disclosed above are equally possible within the scope of the inventive concept as defined by the appended claims.

[0093] Some aspects of the invention are described in the following clauses.

[0094] 1. A subassembly (1) of a drug delivery device, the subassembly (1) comprising:

[0095] a tubular outer cap (10) extending along a longitudinal axis (L);

[0096] an inner cap (12) at least partially surrounded by the tubular outer cap (10); wherein the inner cap (12) is configured to be removably attached to the housing of the drug delivery device via a rotational attachment;

[0097] A clutch, the clutch comprising a driving part (101) and a driven part (132)

[0098] form;

[0099] wherein the driven portion (132) is attached to the inner cap (12) and is positioned between the tubular outer cap (10) and the inner cap (12) in a direction transverse to the longitudinal axis (L);

[0100] wherein the outer cap (10) is axially movable relative to the inner cap (12) between a proximal position and a distal position;

[0101] wherein the tubular outer cap (10) comprises the driving portion (101), and the driving portion (101) extends from the main body (100) of the tubular outer cap (10);

[0102] wherein the driven portion (132) extends toward the tubular outer cap (10) in the direction transverse to the longitudinal axis; wherein when the tubular outer cap (10) is in the proximal position, the driving portion (101) is in contact with the driven portion (132) in the direction of the longitudinal axis (L).

[0103] spaced apart; and wherein when the tubular outer cap (10) is in the distal position, the drive portion (101) is adjacent to the driven portion (132), so that the inner cap can be separated from the housing of the drug delivery device via rotation of the outer cap (10) relative to the housing of the drug delivery device.

[0104] 2. The subassembly (1) according to clause 1, wherein the driven portion extends from the main body wall of the inner cap in the direction transverse to the longitudinal axis (L).

[0105] 3. A subassembly (1) according to claim 1, wherein the subassembly includes an interlocking sleeve (13); wherein the interlocking sleeve (13) includes a main body (130) extending along the longitudinal axis (L); wherein the interlocking sleeve (13) includes a rotating sleeve fastener (133) engaged with a matching rotating sleeve fastener (121) of the inner cap (12); and wherein the driven portion (132) extends from the main body (130) of the interlocking sleeve (13) in the direction transverse to the longitudinal axis (L).

[0106] 4. A subassembly according to any of the preceding clauses, wherein one of the driving portion (101) and the driven portion (132) is a recess; and wherein the other of the driving portion (101) and the driven portion (132) is a recess;

[0107] The outer cap (10) is positioned in the recess when the outer cap (10) is in the distal position.

[0108] 5. The subassembly of clause 4, wherein the recess faces in the direction transverse to the longitudinal axis.

[0109] 6. A subassembly according to clause 4 or 5, wherein the recess is formed by a ratchet.

[0110] 7. A subassembly according to any of the preceding clauses, wherein clutch engagement between the driving portion and the driven portion is formed by a non-circular cross-sectional body of the driving portion matching a non-circular cross-sectional body of the driven portion.

[0111] 8. A subassembly according to any of the preceding clauses, wherein the clutch engagement formed between the drive part and the driven part is a friction fit engagement.

[0112] 9. A subassembly according to any of the preceding clauses, comprising and a retainer (11); wherein the retainer comprises a retainer body (110) and an attachment (11a) extending from the retainer body (110); wherein the attachment (11a) is configured to be attached to a mating attachment of the drug delivery device; wherein

[0113] The inner cap (12) is removably attached to the holder (11) via the rotational attachment, whereby the inner cap (12) is removably attached to the medication delivery device via the holder (11).

[0114] 10. A subassembly according to clause 9, wherein the rotational attachment is formed by a thread (111) of the retainer body (110) and a threaded follower (123) of the inner cap (12) engaged with the thread (111) of the retainer (11).

[0115] 11. A subassembly according to clause 9 or 10, comprising a delivery member hub (14) configured to be attached to a drug delivery member; wherein the delivery member hub (14)

[0116] It includes a first engagement member (141) engaged with a first mating engagement member (112) of the retainer (11); and a second engagement member (142) engaged with a mating second engagement member (124) of the inner cap (12); and wherein the delivery member hub (14) is capable of axially moving between a proximal position and a distal position relative to the retainer body (110).

[0117] 12. The subassembly of clause 11, wherein rotation of the inner cap (12) relative to the retainer (11) is configured to move the delivery member hub (14) from the proximal position to the distal position.

[0118] 13. A subassembly according to clause 12 which is subordinate to clause 10, wherein the engagement formed between the first engagement member and the mating first engagement member is a threaded engagement; wherein the engagement formed between the second engagement member and the mating second engagement member is a rotational engagement; and wherein the threaded engagement between the delivery member hub and the retainer points in a longitudinal direction opposite to the threaded engagement between the inner cap and the retainer.

[0119] 14. A subassembly according to claim 12, wherein the delivery member hub is rotationally fixed to the retainer body; wherein one of the second engaging member and the mating second engaging member is a spiral cam, and the other of the second engaging member and the mating second engaging member is a cam follower; and wherein the engagement formed between the first engaging member and the mating first engaging member is a snap-fit ​​engagement.

[0120] 15. The subassembly according to any of clauses 9 to 14, wherein the attachment (11a) of the retainer (11) is one of a snap-fit ​​attachment, a threaded attachment and a bayonet attachment.

[0121] 16. A subassembly according to any of the preceding clauses, comprising a delivery member guard (2) and a locking member (3); wherein the delivery member guard (2)

[0122] comprising a proximal reference surface (20a) adjacent to a distal reference surface (102) of the tubular outer cap (10); wherein the delivery member guard (2) comprises a distal reference surface (22a); wherein the locking member (3) comprises a body (30) having a proximal reference surface (31a);

[0123] The locking member (3) is capable of moving between a locking position and an unlocking position relative to the delivery member guard (2), wherein in the locking position, the proximal reference surface (31a) of the locking member (3) is aligned with the distal reference surface (22a) of the delivery member guard (2), thereby preventing the delivery member guard (2) from moving distally relative to the locking member (3), and in the unlocking position, the proximal reference surface (31a) of the locking member (3) is offset toward the distal reference surface (22a) of the delivery member guard (2), thereby enabling the delivery member guard (2) to move distally relative to the locking member (3).

[0124] 17. Subassembly according to clause 16, wherein the locking member (3) is rotatable relative to the delivery member guard (2) about the longitudinal axis (L) between the locked position and the unlocked position.

[0125] 18. The subassembly of clause 16, wherein the locking member is slidable relative to the delivery member guard in the direction transverse to the longitudinal axis.

[0126] 19. A medication delivery device comprising a subassembly according to any of the preceding clauses, wherein the medication delivery device is an autoinjector.

[0127] 20. A cassette unit (C) of a drug delivery device, the cassette unit comprising a subassembly according to clause 17 or 18, wherein the cassette unit comprises the housing (4) of the drug delivery device; wherein the housing (4) extends along the longitudinal axis (L); and wherein the locking member (3) is axially fixed to the housing (4).

[0128] 21. A cassette unit (C) according to clause 20 when dependent on clause 17, wherein the delivery member guard (2) is rotationally fixed to the housing (4), wherein the housing (4) comprises a bayonet protrusion (40) configured to move along a bayonet track of a drive unit (R) of the drug delivery device, thereby attaching the cassette unit (C) to the drive unit (R); wherein the locking member (3)

[0129] It includes a protrusion (32) extending from the main body (30) away from the longitudinal axis (L); wherein the protrusion (32) is adjacent to the bayonet protrusion (40) of the housing (4) in the direction of the longitudinal axis (L); and wherein the protrusion (32) is configured to be rotationally fixed to the wall of the drive unit (R) when the cassette unit is attached to the drive unit (R).

[0130] 22. A method for removing a cap of a drug delivery device, wherein the drug delivery device comprises a cassette unit and a drive unit according to clause 20, the method comprising the following steps in the following order:

[0131] moving the locking member from the locked position to the unlocked position;

[0132] moving the tubular outer cap and the delivery member guard in a distal direction relative to the inner cap to the distal position of the tubular outer cap;

[0133] The tubular outer cap and the inner cap are rotated relative to the housing of the cassette unit, thereby separating the tubular outer cap and the inner cap from the housing of the cassette unit.

[0134] 23. A method according to clause 22, wherein the drug delivery device comprises a cassette unit according to clause 21, wherein the step of moving the locking member from the locked position to the unlocked position comprises the following step: rotating the locking member relative to the delivery member guard from the locked position to the unlocked position.

[0135] 24. The method according to clause 23, wherein the step of rotating the locking member relative to the delivery member guard from the locked position to the unlocked position comprises the following steps:

[0136] During attachment of the cassette unit to a drive unit via the bayonet connection, the locking member is rotated relative to the delivery member guard from the locked position to the unlocked position.

[0137] 25. The method according to any one of clauses 22 to 23, when the cassette unit comprises a subassembly according to any one of clauses 11 to 14, wherein the step of rotating the tubular outer cap and the inner cap relative to the housing further comprises the following steps:

[0138] During rotation of the tubular outer cap and the inner cap relative to the housing, the delivery member hub is moved from the proximal position to the distal position, thereby mounting the delivery member attached to the delivery member hub to a medicament container having the housing of the medicament delivery device.

Claims

1. A subassembly (1) of a drug delivery device, the subassembly (1) comprising: a tubular outer cap (10) extending along a longitudinal axis (L); an inner cap (12) at least partially surrounded by the tubular outer cap (10); wherein the inner cap (12) is configured to be removably attached to the housing of the drug delivery device via a rotational attachment; A clutch, the clutch being formed by a driving part (101) and a driven part (132); wherein the driven portion (132) is attached to the inner cap (12) and is positioned between the tubular outer cap (10) and the inner cap (12) in a direction transverse to the longitudinal axis (L); wherein the outer cap (10) is axially movable relative to the inner cap (12) between a proximal position and a distal position; The tubular outer cap (10) comprises the driving portion (101), which extends from the main body (100) of the tubular outer cap (10); wherein the driven portion (132), which extends toward the tubular outer cap (10) in the direction transverse to the longitudinal axis; wherein when the tubular outer cap (10) is in the proximal position, the driving portion (101) is spaced apart from the driven portion (132) in the direction of the longitudinal axis (L); and wherein when the tubular outer cap (10) is in the distal position, the driving portion (101) is adjacent to the driven portion (132), so that the inner cap can be separated from the housing of the drug delivery device via rotation of the outer cap (10) relative to the housing of the drug delivery device.

2. A subassembly (1) according to claim 1, wherein the subassembly includes an interlocking sleeve (13); wherein the interlocking sleeve (13) includes a main body (130) extending along the longitudinal axis (L); wherein the interlocking sleeve (13) includes a rotating sleeve fastener (133) engaged with a matching rotating sleeve fastener (121) of the inner cap (12); and wherein the driven portion (132) extends from the main body (130) of the interlocking sleeve (13) in the direction transverse to the longitudinal axis (L).

3. A subassembly according to any one of the preceding claims, wherein one of the drive portion (101) and the driven portion (132) is a recess; and wherein the other of the drive portion (101) and the driven portion (132) is a protrusion positioned in the recess when the tubular outer cap (10) is in the distal position. The subassembly of claim 3 , wherein the recess faces in the direction transverse to the longitudinal axis.

5. A subassembly according to any one of the preceding claims, comprising a retainer (11); wherein the retainer comprises a retainer body (110) and an attachment (11a) extending from the retainer body (110); wherein the attachment (11a) is constructed to be attached to a mating attachment of the drug delivery device; wherein the inner cap (12) is removably attached to the retainer (11) via the rotational attachment, whereby the inner cap (12) is removably attached to the drug delivery device via the retainer (11).

6. The subassembly according to claim 5, wherein the rotational attachment is formed by a thread (111) of the retainer body (110) and a thread follower (123) of the inner cap (12) engaging with the thread (111) of the retainer (11).

7. A subassembly according to claim 5 or 6, wherein the subassembly includes a delivery member hub (14) constructed to be attached to a drug delivery member; wherein the delivery member hub (14) includes a first engagement member (141) engaged with a first mating engagement member (112) of the retainer (11); and a second engagement member (142) engaged with a mating second engagement member (124) of the inner cap (12); and wherein the delivery member hub (14) is capable of axially moving between a proximal position and a distal position relative to the retainer body (110).

8. The subassembly of claim 7, wherein rotation of the inner cap (12) relative to the retainer (11) is configured to move the delivery member hub (14) from the proximal position to the distal position.

9. A subassembly according to claim 8 as dependent on claim 6, wherein the engagement formed between the first engagement member and the mating first engagement member is a threaded engagement; wherein the engagement formed between the second engagement member and the mating second engagement member is a rotational engagement; and wherein the threaded engagement between the delivery member hub and the retainer points in a longitudinal direction opposite to the threaded engagement between the inner cap and the retainer.

10. A subassembly according to claim 8, wherein the delivery member hub is rotationally fixed to the retainer body; wherein one of the second engaging member and the mating second engaging member is a spiral cam, and the other of the second engaging member and the mating second engaging member is a cam follower; and wherein the engagement formed between the first engaging member and the mating first engaging member is a snap-fit ​​engagement.

11. The subassembly according to any one of claims 5 to 10, wherein the attachment (11a) of the retainer (11) is one of a snap-fit ​​attachment, a threaded attachment and a bayonet attachment.

12. A subassembly according to any one of the preceding claims, comprising a delivery member shield (2) and a locking member (3); wherein the delivery member shield (2) comprises a proximal reference surface (20a) adjacent to the distal reference surface (102) of the tubular outer cap (10); wherein the delivery member shield (2) comprises a distal reference surface (22a); wherein the locking member (3) comprises a body (30) having a proximal reference surface (31a); wherein the locking member (3) is capable of being locked relative to the delivery member shield (2) in a locked position. The locking member (3) moves between an unlocked position, in which the proximal reference surface (31a) of the locking member (3) is aligned with the distal reference surface (22a) of the delivery member shield (2), so that the delivery member shield (2) is prevented from moving distally relative to the locking member (3), and in the unlocked position, the proximal reference surface (31a) of the locking member (3) is offset toward the distal reference surface (22a) of the delivery member shield (2), so that the delivery member shield (2) can move distally relative to the locking member (3).

13. The subassembly according to claim 12, wherein the locking member (3) is rotatable relative to the delivery member guard (2) about the longitudinal axis (L) between the locked position and the unlocked position.

14. A cassette unit (C) of a drug delivery device, the cassette unit comprising a subassembly according to claim 13, wherein the cassette unit comprises the housing (4) of the drug delivery device; wherein the housing (4) extends along the longitudinal axis (L); and wherein the locking member (3) is axially fixed to the housing (4).

15. A cassette unit (C) according to claim 14 when dependent on claim 13, wherein the delivery member guard (2) is rotationally fixed to the housing (4), wherein the housing (4) includes a bayonet protrusion (40), which is constructed to move along a bayonet track of a drive unit (R) of the drug delivery device, thereby attaching the cassette unit (C) to the drive unit (R); wherein the locking member (3) includes a protrusion (32) extending from the body (30) away from the longitudinal axis (L); wherein the protrusion (32) is adjacent to the bayonet protrusion (40) of the housing (4) in the direction of the longitudinal axis (L); and wherein the protrusion (32) is constructed to be rotationally fixed to the wall of the drive unit (R) when the cassette unit is attached to the drive unit (R).